Global Metagenomic Sequencing Market Overview, Segmentation, Key Developments And Forecast

Metagenomic Sequencing Market Size And Forecast

Metagenomic Sequencing Market was valued at USD 448.04 Million in 2019 and is projected to reach USD 729.34 Million by 2027, growing at a CAGR of 6.3% from 2020 to 2027.

Global Metagenomic Sequencing Market Overview

The development of Next Generation DNA Sequencing (NGS) technology has considerably shaped molecular biology research, which has led to several discoveries and new insights. Next-generation DNA sequencing technology goes beyond long-established DNA sequencing with its applications that reach across the principles of molecular biology. Thus, it can be stated that the rise in technological advancements regarding DNA sequencing will drive the market.

Global Metagenomic Sequencing Market: Segmentation

The Metagenomic Sequencing market is segmented on the basis of workflow, product & services, technology, application, and geography.

The major players in the market are Illumina, Thermo Fisher Scientific, Pacific Biosciences of California. Qiagen, BGI, Perkinelmer and Oxford Nanopore Technologies, Eurofins Genomics, GATC Biotech., and Macrogen.

1 Introduction of Global Metagenomic Sequencing Market

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 Global Metagenomic Sequencing Market Outlook

4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 Global Metagenomic Sequencing Market, by Workflow

5.1 Overview
5.2 Sample Preparation
5.3 Sequencing
5.4 Data Processing and Analysis

6 Global Metagenomic Sequencing Market, by Products and Services

6.1 Overview
6.2 Instruments
6.3 Reagents and Consumables
6.4 Analysis and Data Interpretation Solutions
6.5 Metagenomic Sequencing Services

7 Global Metagenomic Sequencing Market, by Technology

7.1 Overview
7.2 Shotgun Metagenomic Sequencing
7.3 16S Rrna Sequencing
7.4 Whole-Genome Sequencing and De Novo Assembly
7.5 Metatranscriptomics

8 Global Metagenomic Sequencing Market, by Application

8.1 Overview
8.2 Ecological and Environmental Metagenomics
8.3 Clinical Diagnostic Metagenomics
8.4 Drug Discovery Metagenomics
8.5 Soil Microbiome
8.6 Industrial Applications
8.7 Others

9 Global Metagenomic Sequencing Market, by Geography

9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World

10 Global Metagenomic Sequencing Market Competitive Landscape

10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 Company Profiles

11.1 Illumina
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Thermo Fisher Scientific
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Pacific Biosciences of California
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Qiagen
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Bgi
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Perkinelmer
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Oxford Nanopore Technologies
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Eurofins Genomics
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Gatc Biotech.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Macrogen
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

12 Appendix

12.1 Related Reports